ATF3/4 was found to induce NOXA expression by binding to NOXA promoter in head and neck squamous cell carcinoma (HNSCC) in response to cisplatin treatment [141]. This evidence concerns the gene PMAIP1 and head and neck squamous cell carcinoma.